COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial

(University of Alabama at Birmingham) The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.